SCHEMBL782285

SCHEMBL782285

CC1(C)c2ccccc2-c2cc3c4cc(Br)ccc4n(-c4ccccc4)c3cc21

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 3/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ DNMT1 P26358 1/20 0.34
▸ PDE4B Q07343 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ GSK3B P49841 6/20 0.32
▸ CCNB2 O95067 3/20 0.32
▸ CDK1 P06493 3/20 0.32
▸ CCNB1 P14635 3/20 0.32
▸ CCNB3 Q8WWL7 3/20 0.32
▸ LIG1 P18858 1/20 0.31
▸ QPCT Q16769 1/20 0.31
▸ DNM1 Q05193 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30866249 1.00 PGR (0.35) PGRL3MBTL1KDM4EATMALDH1A1
SCHEMBL8819147 0.95 PGR (0.35) PGRL3MBTL1KDM4EATMALDH1A1
SCHEMBL782446 0.93 MDM2 (0.32) PGRALDH1A1DNMT1PDE4BPDK2
SCHEMBL20259997 0.91 PGR (0.33) PGRL3MBTL1KDM4EATMALDH1A1
SCHEMBL18351606 0.90 L3MBTL1 (0.38) L3MBTL1KDM4EATMALDH1A1RXFP1
SCHEMBL15582883 0.90 TSPO (0.31) DNMT1GSK3BQPCT
SCHEMBL783405 0.90 HDAC4 (0.35) L3MBTL1KDM4EATMRXFP1GSK3B
SCHEMBL24099545 0.89 PDE4B (0.31) PGRPDE4B
SCHEMBL14979129 0.89 PGR (0.33) PGRL3MBTL1KDM4EATM
SCHEMBL12093468 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
US-20230210004-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-29 — — US disclosed
US-20230210004-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-29 — — US disclosed
US-11588117-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-02-21 — — US disclosed
US-11201296-B2 Compounds having fluorene structures MERCK PATENT GMBH (DE) 2021-12-14 — — US disclosed
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same SFC CO., LTD. (KR) 2021-07-27 — — US disclosed
EP-3806176-A1 ELECTRONIC DEVICE Merck Patent GmbH (DE) 2021-04-14 — — EP disclosed
EP-2915199-B1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2021-03-31 — — EP disclosed
EP-3055303-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-12-02 — — EP disclosed
US-20120223276-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-09-06 — — US disclosed
US-20120223276-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-09-06 — — US disclosed
US-20120223276-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-09-06 — — US disclosed
WO-2012069121-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-05-31 — — WO disclosed
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-03-22 — — US disclosed
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-03-22 — — US disclosed
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-03-22 — — US disclosed
WO-2011060867-A1 NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUNDS FOR OLEDS MERCK PATENT GMBH (DE) 2011-05-26 — — WO disclosed
WO-2011057706-A2 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-05-19 — — WO disclosed
WO-2010136109-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 PGR 1812/4885L3MBTL1 1480/4885KDM4E 710/4885
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same HARS1, ALDH1A2, NR2E3 PGR 1993/4885L3MBTL1 562/4885KDM4E 3813/4885
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SLCO2B1, SLCO1B3, SLCO4C1 PGR 1496/4885L3MBTL1 3941/4885KDM4E 1899/4885
US-20230210004-A1 MATERIALS FOR ELECTRONIC DEVICES EPHB3, EPHA3, EPHB4 PGR 1417/4885L3MBTL1 1854/4885KDM4E 1241/4885
US-11588117-B2 Materials for electronic devices EPHB3, EPHA3, EPHB4 PGR 1417/4885L3MBTL1 1854/4885KDM4E 1241/4885
US-11201296-B2 Compounds having fluorene structures FSCN1, EFNA1, FLNA PGR 2270/4885L3MBTL1 4011/4885KDM4E 3228/4885
US-20120223276-A1 MATERIALS FOR ELECTRONIC DEVICES ERCC1, XPOT, EMD PGR 750/4885L3MBTL1 4450/4885KDM4E 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback